
|Articles|November 23, 2022
Incyte Biosciences United Kingdom and Ireland Appoints Peter Williams As General Manager
Advertisement
Incyte announces the appointment of Peter Williams as General Manager for Incyte Biosciences United Kingdom and Ireland. In his role, Peter will be responsible for the development of medical, regulatory and commercial strategy for Incyte’s portfolio of products in the UK and Ireland.
“On behalf of our leadership team, I would like to welcome Peter to Incyte. His extensive commercial experience will greatly enhance the teams in the UK & Ireland and support our continued growth,” said Jonathan Dickinson, Executive Vice President and General Manager for Incyte Europe.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5




